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Induction of Emphysematous Lesions in Rat Lung by ß-D-xyloside, 
an Inhibitor of Proteoglycan Synthesis
Toin H. van Kuppevelt, Chris H. A. van de Lest, Elly M. M. Versteeg, P. N. Richard Dekhuijzen, 
and Jacques H. Veerkamp
Departments of Biochemistry and Pulmonary Diseases, University of Nijmegen, Nijmegen, the Netherlands
The possible involvement of proteoglycans in the pathogenesis of emphysema was studied in rats by a sin­
gle intratracheal instillation of /?-nitrophenyl-j9-D-xylopyranoside (jS-D-xyloside), an inhibitor of pro­
teoglycan synthesis. The first 3 days after instillation are characterized by mild hemorrhages, some infiltra­
tion of inflammatory cells, and edema. After 1 wk, lung morphology is normal again. Forty days after 
instillation, considerable parenchymal destruction has occurred as determined by the mean linear intercept 
(81 ±  12 ¿uni versus 57 ±  5 ¡xm for control [P  <  0.001J). Pulmonary fibrosis is not observed. Instillation 
with /7-nitrophenyl-o:-D-xylopyranoside and p-nitrophenol do not induce parenchymal destruction, indi­
cating the specificity of /5-D-xyloside action. Urinary glycosaminoglycan (GAG) content of the /3-D- 
xyloside-treated rats is increased 15-fold during the first day after instillation, mainly due to elevated levels 
of chondroitin sulfate and dermatan sulfate. The increase is correlated to the extent of parenchymal de­
struction after 40 days (r =  0.68; P < 0.002). At day 2 and thereafter, levels are normal again. A short-term 
increase in dermatan and chondroitin sulfate content is also observed in serum, bronchoalveolar lavage 
(BAL) fluid, and lung tissue. Heparan sulfate content is decreased in BAL fluid and lung tissue. Instillation 
with /?-nitrophenyl-a:-D-xylopyranoside and /7-nitrophenol do not induce elevated GAG concentration in 
urine. We suggest that a disturbance in proteoglycan synthesis accompanied by an increase of (|3-D- 
xyloside-primed) free GAGs results in loss of stability and integrity of the alveolar wall, leading to paren­
chymal destruction and emphysematous lesions. |3-D-xyloside treatment may be an alternative experimen­
tal method for inducing emphysema, van Kuppevelt, T. H ., C. H. A. van de Lest, E. M. M. Versteeg, 
P. N. R. Dekhuijzen, and  J. H. Veerkamp. 1997. Induction  of emphysematous lesions in rat lung 
by /3-D-xyloside, an  inhibitor of proteoglycan synthesis. A m . J. Respir. Cell Mol. Biol. 16:75-84.
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The predominant theory on the pathogenesis of emphysema pear to be complex and other macromolecules of the alve- 
is contained in the protease/antiprotease concept (1-3). A olar wall should be considered. A major component in the 
relative surplus of proteases causes degradation of the al veo- nonfibrillar part of the extracellular matrix of alveoli is pro- 
lar elastic fiber matrix, leading to a destruction of the alveo- teoglycans. Proteoglycans consist of a core protein to which 
lar walls. Elastin degradation is believed to be pivotal in this one or more strongly negatively charged glycosaminoglycan
(GAG) side chains are covalently attached. In the alveolar 
wall several proteoglycans are present including heparan sul­
fate proteoglycans (e.g., the basement membrane-associated 
perlecan and the cell membrane-associated syndecans) and 
collagenase (7). Thus the causes of alveolar destruction ap- dermatan/chondroitin sulfate proteoglycans (e.g., the colla­
gen fibril-associated decorin, and biglycan) (8).
Several characteristics of proteoglycans make them likely
(Received in original form  September 20, 1995 and in fin a l fo rm  June 10, candidates for playing a key role in the maintenance of the
/996) structural integrity of the alveolar wall. They interact with
Address correspondence to: T. H. van Kuppevelt, Department of Biochem- and modulate several classes of molecules, including growth
istry, University of Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, the Neth­
erlands.
respect. However, several animal models have been 
scribed in which air space enlargement/emphysema is not 
accompanied by elastin degradation. These include emphy­
sema induced by CdCli (4, 5), by 90% oxygen (6), and by
Abbreviations: bronchoalveolar lavage, BAL; bovine serum albumin, BSA;
1,9-dimethylmethylene blue, DMMB; diethylaminoethyl, DEAE; dimethyl 
sulfoxide, DMSO; glycosaminoglyean(s), GAG(s); mean linear intercept,
factors and extracellular matrix molecules (9-13); act as 
powerful protease inhibitors, e .g ., for leukocyte elastase and 
cathepsin G (14-16); are involved in fibrillogenesis of colla­
gen and elastin and can modulate their mechanical charac-
MLI; phosphate-buffered saline, PBS; p-nitrophenyl-j8-D-xylopyranosidc, teristics (17-19); offer protection against proteolysis of COlla- 
0-D-xyioside; p-nitrophenyi-cv-D-xyiopyranoside, a-D-xyloside. gen and elastin (20-22); and have a high water-binding
Am. j. Respir. Cell Moi. Biol. Vol. 16. pp. 75-84, 1996 capacity, providing resilience to the alveolar wall (23). In ad-
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dition, the close association of proteoglycans with structural 
elements in the alveolar wall (e.g., basement membranes, 
collagen fibrils, and elastic fibers) indicates a structural role.
Since the structural integrity of alveoli is compromised 
in emphysema, alterations in the proteoglycan composition 
should be considered as a factor contributing to the patho­
genesis of emphysema. Proteoglycans have been almost en­
tirely neglected in studies on emphysema (24). Previously 
we showed that proteoglycans are target molecules for pan­
creatic elastase instilled into rat lung (25). Now, to eval­
uate the importance of proteoglycans in alveolar wall stabil­
ity and in the pathogenesis of emphysema, we studied the 
effect of a single intratracheal instillation of /?-nitrophenyl- 
/3-D-xylopyranoside (j8-D-xyloside), which is an inhibitor 
of proteoglycan synthesis (26). As control agents we ap­
plied /j-nitrophenyl-a-D-xyloside (a-D-xyloside) and /7-nitro- 
phenol. The a-D-xyloside does not change proteoglycan 
synthesis via the false acceptor pathway, in contrast to the 
0-D-xyloside, and can be used to discern between the pro­
teoglycan synthesis-disturbing effect of jS-D-xyloside and 
other effects (27).
vol % dimethyl sulfoxide (DMSO) in 0.14 M NaCl; 0.5 ml
Materials and Methods
1,9-DimethyImethylene blue (DMMB) (80% pure) was pur­
chased from Aldrich Chem. Co. (Bornem, Belgium); Uni­
versal Gel/8 1% agarose gels from Ciba-Corning GMBH 
(Fernwald, Germany); halothane from Apharmo (Arnhem, 
the Netherlands); pentobarbital (Narcovet) from ICI-Farma 
(Rotterdam, the Netherlands); diethylaminoethyl (DEAE)- 
Sepharose Fast Flow from Pharmacia (Uppsala, Sweden); 
;?-nitrophenol, aquamount, and cetyl-trimethyl-ammonium- 
bromide from BDH Ltd. (Poole, UK); and Azure A, Tween- 
20, whale cartilage chondroitin 4-sulfate, bovine kidney 
heparan sulfate, porcine pancreatic elastase, bovine serum 
albumin (BSA), ¿3-D-xylopyranoside, a-D-xylopyranoside, 
Ar-methylsuccinyl-ala-ala-pro-val7-amino-4-methyl-couma- 
rin, fluoresceinisothiocyanate-conjugated goat antimouse 
IgM, and mouse antichondroitin sulfate (clone CS-56) from 
Sigma Inc. (St. Louis, MO). Mouse monoclonal antiheparan 
sulfate (JM403) antibody was obtained and characterized as 
described (28).
P5SJGAGs (specific activity 6 X 10' Bq//zg GAG) were
twice i.p. with 37,000 Bq
40 niM j3-D-xyloside (20 /xmol) in 0.14 M NaCl; 0.5 ml 50 
mM a-D-xyloside (25 ¿imol) in 10 vol % DMSO in 0.14 M 
NaCl; 0.5 ml 100 mM /?-nitrophenol (50 /¿mol) in 10 vol % 
DMSO in 0.14% NaCl; 0.5 ml porcine pancreatic elastase
obtained from rats
Nay'sSO.i/g body weight with a 4-h time span between in­
jections. Four hours after the second injection the rats were 
killed and the soft tissues (i.e., liver, kidney, intestine, etc.) 
removed. GAGs were extracted by alkaline borohydride (29).
Animal Accommodation
Rats were accommodated in groups of three and fed ad lib.
For urine collection, they were accommodated separately in 
metabolic cages. To avoid stress factors, rats were habituated 
to these cages for 7 days before treatment.
I ntratracheal Instillation
Male Wistar rats (200 ±  10 g) were anesthetized with 3% 
halothane, intubated, and artificially respirated according to 
Mauderly (30). Rats were hyperventilated to stop breathing
lor a few seconds, and were instilled during this time span Isolation of GAGs from Serum
with either 0.5 ml 200 mM /3-D-xyloside (100 ¿imol) in 10 To 100 n 1 serum, 8 /¿I trichloroacetic acid solution (1 g/ml)
(0.2 IU/g body weight) in 0.14 M NaCl; 0.5 ml 10% DMSO 
in 0.14 M NaCl; or 0.5 ml 0.14 M NaCl. Maximal doses of 
a-D-xyloside and p-nitrophenol were applied (25 and 50 
/jmol, respectively); higher doses were lethal. All solutions 
were administered at 37°C. After instillation, rats were res­
pirated until they awoke.
Histology
Animals were killed by an overdose of pentobarbital injected 
i.p. For morphometric studies, lungs were dissected and 
fixed with 2% formaldehyde in 150 mM phosphate buffer 
(pH 7.2) administered through a polyethylene catheter in­
serted into the trachea at a pressure of 25 cm H,0. After 
30 min, lungs were fixed for an additional 24 h in 4% formal­
dehyde, dehydrated, and embedded in paraffin. Tissue sec­
tions (6 ¡xm) were contrasted using the trichrome staining 
method of Goldner (31). To assess the degree of air-space en­
largement, the mean linear intercept (MLI) was determined 
using a Mop-videoplan image analyser (Kontron GMBH, 
Eching, Miinchen, Germany).
For immunofluorescence and biochemical studies, lungs 
were dissected and inflated through the trachea with 5 ml 
phosphate-buffered saline (PBS) (pH 7.2). PBS-filled lungs 
were frozen in liquid nitrogen and stored at —70°C. Cryosec- 
tions (6 /¿m) were rehydrated for 10 min in PBS, containing 
1% BSA. Antibodies were applied for 1.5 h in PBS contain­
ing 1% BSA. After each antibody incubation, sections were 
washed in PBS (3 times for 5 min). Antiheparan sulfate anti­
bodies and all secondary antibodies were used at a dilution 
of 1:100. All other antibodies were used at 1:50. Sections 
were embedded in aquamount and examined on a Zeiss ax- 
ioskop photomicroscope (Carl Zeiss, Oberkochen, Germany).
Isolation of GAGs from Urine and BAL Fluid
Bronchoalveolar lavage (BAL) fluid was obtained from the 
left lung by washing the dissected lung once with 4 ml and
4 times with 2 ml PBS (4°C). Cells were removed from BAL 
fluid by centrifugation (1,000 x g,  10 min, 4°C). The total 
yield of BAL fluid was 10 ml.
Rat urines were collected 1 day before to 7 days after in­
stillation (each day). Urine was centrifuged at 2,000 X # for 
10 min (4°C), and 20 ml of the supernatant was diluted to 
50 ml by adding 10 mM Tris-HCl (pH 6.8).
GAGs were purified from urine and BAL fluid by anion
exchange chromatography as described (25). Urine samples 
(50 ml) or BAL fluids (7 ml) were loaded onto a column of
5 X  0.5 cm containing 0.5 ml DEAE-Sepharose Fast Flow. 
After an initial wash with 3 ml 0.2 M NaCl/10 mM Tris-HCl 
(pH 6.8), GAGs were eluted with 1 ml 2 M NaCl/10 mM 
Tris-HCl (pH 6.8) followed by 3 ml 10 mM/Tris-HCl (pH 
6.8). Recovery of urinary GAGs was monitored by adding
9 X  105 Bq [^SJGAG to the urine sample and was between 
72 and 101%.
van Kuppevelt, van de Lest, Versteeg, et al. : /3-D-xyloside-induced Emphysematous Lesions 77
was added. After centrifugation for 20 min at 10,000 X  g ,  nium-bromide was added. After 5 min preincubation at
the supernatant was removed and stored on ice. The protein 37°C, 5 fx 1 substrate solution (10 mM /V-methylsuccinyl-ala-
bound GAGs were liberated from the pellet by /3-elimination ala-pro-val7-amino-4-methyl-eoumarin dissolved in DMSO)
as follows. The pellet was suspended in 100 ¡x\ 0.75 M 
NaOH/50 mM NaBH4 and incubated for 1 h at 73°C. After 
1 h the mixture was cooled on ice and neutralized with 6 M
was added. Fluorescence was monitored on a Shimadzu RF- 
5000 spectrofluorometer at excitation and emission wave­
lengths of 375 and 440 nm, respectively. Human leukocyte
HC1. The remaining proteins were removed by addition of elastase, a generous gift of Dr. J. Schalkwijk (Department 
9 ¡x1 trichloroacetic acid solution (I g/ml) and centrifugation of Dermatology, University of Nijmegen), was taken as a 
(20 min, 10,000 x  g). The supernatants of both precipita­
tions were pooled and 5 vol of 100% ethanol were added.
Alter 16 h at —20°C the mixture was centrifuged for 30 min
standard.
Statistical Analysis
at 15,000 x  g (0°C), and the precipitated GAGs were dried, Intergroup comparison was calculated using Student’s / test,
dissolved in 50 ¡x\ 50 mM barium acetate (pH 5.0)/40% Correlation analysis was performed using Pearson’s product
glycerol/0.01 % bromophenol blue, and subjected to agarose moment correlation test (36). All values are given as mean
gel electrophoresis (see below). ±  SD.
Isolation of GAGs from Parenchymal Lung Tissue
GAGs were extracted according to a modified method of 
Hoffman (29). Pleura, large airways and blood vessels were 
removed from 30-ju.m-thick cryosections. The remaining tis­
sue was lyophilized, weighed, and suspended in 200 ¡xl 0.75 
M NaOH/lO mM NaBH4. After 1 h at 73°C, the mixture 
was neutralized with 6 M HC1 and trichloroacetic acid was 
added to a final concentration of 60 mg/ml. After 1 h at 4°C 
and centrifugation for 15 min at 2,000 x  g (4°C), the pellet 
was dissolved in 100 ¡x\ 100 mM  NaOH and the protein con­
centration determined according to Lowry and colleagues 
(32). To the GAGs-containing supernatant, 5 vol of 100% 
ethanol were added and after 16 h at —20°C the mixture was 
centrifuged (30 min, 15,000 X  g ,  4°C). The precipitated 
GAGs were dried and dissolved in demineralized water.
Quantification of GAGs by Gel Electrophoresis
GAG samples from urine, BAL fluid, serum, and lung tissue 
were separated on agarose gel using 0.05 M barium acetate 
(pH 5.0) as electrophoresis buffer. GAGs were visualized 
using a combined azure A/silver staining as described, and 
quantified by densitometric analysis (33). The nature of the 
GAGs was established by specific degradation procedures: 
nitrous acid for heparan sulfate, chondroitinase ABC diges­
tion for chondroitin sulfate and dermatan sulfate, and chon­
droitinase AC digestion for chondroitin sulfate (33).
Quantification of Sulfated GAGs by a 
Spectrophotometric Assay
The content of sulfated GAGs was determined using the 
DMMB assay of Farndale and associates (34). To a 100-/J 
GAG sample, 2.5 ml of DMMB-reagent was added and the 
absorbance at 525 nm was measured directly. The DMMB- 
reagent consists of 48 /¿M DM M B (initially 48 jumol DMMB 
was dissolved in 5 ml 96% ethanol), 42 mM glycine, and 42 
mM NaCl, adjusted to pH 3.0 with 1 M HC1. Chondroitin 
4-sulfate was taken as a standard and included within each 
series of assays.
Determination of Elastase in BAL Fluid
Elastase activity was determined using the fluorogenie sub­
strate /V-methylsuccinyl-ala-ala-pro-val 7-amino-4-methyl- 
coumarin according to Castillo and colleagues (35), with 
some modifications. Briefly, to 400 /¿I BAL fluid, 100 /xl 4 M 
NaCl/500 mM Tris (pH 8.5)/0.4% cetyl-trimethyl-ammo-
Results
General Morphology
Three hours after intratracheal instillation of 100 nmol (3- 
D-xyloside, mild hemorrhages and some infiltration of 
inflammatory cells are observed in the lung. These phe­
nomena subside 3 days after instillation and lung morphol­
ogy returns to normal after 1 wk. The extent of hemorrhages 
and infiltration of inflammatory cells is much less pro­
nounced compared to elastase-treated animals (Figure 1). 
Animals instilled with a-D-xyloside, /j-nitrophenol, 10% 
DMSO, or physiologic salt display less hemorrhages and 
inflammation than /3-D-xyloside-treated rats. Edema is ob­
served in bronchioli, blood vessels, and alveolar walls until 
day 5 after /3-D-xyloside instillation, whereas other animals 
display only some edema in bronchioli and large blood ves­
sels during the first 2 days. Forty days after treatment, parcn-
chymal destruction is in /3-D-xyloside-treated
animals (Figure 2), as determined by an increase of the MLI
to 81 ±  12 ¡Xm (n = 11) (Figure 3). The MLI is the average 
distance between two alveolar septa and is a parameter of 
air-space enlargement. Occasionally very severe parenchy­
mal destruction is present (Figure 2c). Fibrosis is not ob­
served. The extent of /3-D-xyloside-induced parenchymal 
destruction is comparable to that induced by pancreatic 
elastase (MLI: 82 ±  11 ixm \n = 12] versus 59 ± 4 ¿un |/¿
for control, Figure 3). With a lower dose of /3-D-xylo- 
side (20 /u,mol), only about 30% of the treated animals de­
velop emphysematous lesions (MLI > 70 /¿in) (Figure 3). 
(v-D-xyloside and />-nitrophenol instillation do not induce 
an increase in MLI (56 ± 4 uni 4 |, 54 ±  3 /im
41, res
I in mu nofluorescence Stud ies
Chondroitin sulfate staining is only occasionally present in 
normal rat lung (Figure 4a). Three h and 1 day after 0- 
D-xyloside treatment, however, a diffuse chondroitin sulfate 
staining is observed in the alveolar wall (Figure 4b), which 
changes to a more distinct staining pattern 3 to 7 days after 
treatment (Figure 4c). Phase contrast microscopy indicates 
a colocalization of chondroitin sulfate staining with fiber- 
like structures, presumably elastic fibers (Figures 4c and 
4d). Colocalization of chondroitin sulfate staining with these 
structures can also be observed in alveoli 2 to 14 days after 
pancreatic elastase treatment (data not shown).
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Figure 1. Lung parenchyma 1 day after intratracheal instillation of: (a) 100 ¿trnol 0-D -xyloside in 10% DMSO; (b ) 10% DM SO (control); 
(c) 4 0 IU pancreatic elastase in physiologic salt; (d) physiologic salt (control). In comparison with elastase instillation, ß-D-xyloside-treated 
lungs show little hemorrhages and infiltration of inflammatory cells. Som e perivascular edem a (large arrows) and alveolar transudate {small 
arrows) can be observed. Bar: 100 /¿m.
Heparan sulfate staining was found linearly distributed in 
the alveolar wall, in accordance with its presence in base­
ment membranes. No obvious alterations in heparan sulfate 
staining could be detected in /3-D-xyloside-treated rats (Fig­
ure 5). The distance between the two opposite alveolar base­
ment membranes in the alveolar wall, visualized by heparan 
sulfate staining, is increased (Figure 5). This indicates the 
presence of edema in the alveolar wall (Figure 5).
GAGs in Urine, Serum, BAL Fluid, and Lung
Since /3-D-xyIoside acts as an artificial initiator of GAG syn­
thesis and could cause an increase in the synthesis of free 
GAGs (26), we examined the amount and composition of 
GAGs in BAL fluid, serum, urine, and lung tissue.
In the urine of rats instilled with 100 ¿imol /3-xyloside, a 
15-fold increase in GAG content is observed at day 1, 
whereas in rats instilled with 20 /xmol a 13-fold increase is
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Figure 2. Lung parenchyma 40 days after intratracheal instillation 
of: (a) 10% DMSO; (b ) and (c) 100 ¿imol /3-D-xyloside in 10% 
DMSO. Note the parenchymal destruction in xyloside-treated 
animals. Lesions can occasionally take large dimensions (c). Bar: 
150 urn.
noted (Table 1). cx-D-xyloside and/?-nitrophenol-treated rats 
do not show an increase of GAG excretion (Table 1). At day 
2 and thereafter, urinary GAG levels become normal again 
in (8-D-xyloside-treated rats. The increase in urinary GAG 
can be allotted mainly to an increase in dermatan sulfate and 
chondroitin sulfate, as was determined by agarose gel elec-
En
S
100
80
60
(n~14)
o
40 J 
5 '
.S.
ö
0
!
Control
(n~1 1 )
(n -l 1 )
A
♦
T V
1
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(n-12)
I
1
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Figure 3. Effect of intratracheal instillation of two doses of /3-D-xylo­
side and of pancreatic elastase on the M LI, 40  days after treatment. 
*P < 0.001.
trop ho res is (Figure 6). A significant correlation is found be­
tween the increase of urinary GAG content the first day after 
treatment, and the extent of air-space enlargement (MLI) de­
veloped after 40 days (Figure 7).
In serum, dermatan sulfate and chondroitin sulfate are in­
creased during the first two days after treatment (Table 2). 
Heparan sulfate, which constitutes only 0.3% of serum 
GAGs (32), was not analyzed.
BAL fluid shows the most complex alterations in GAG 
content and composition (Table 3). The major GAG in BAL 
fluid from control animals is heparan sulfate, whereas chon­
droitin sulfate and dermatan sulfate are minor components. 
One hour after /3-D-xyloside treatment, dermatan sulfate 
and chondroitin sulfate contents are dramatically increased, 
which is even more evident after 3 h. One day after treatment 
chondroitin sulfate migrates as a narrow band, indicating 
less heterogeneity in charge and/or size, while dermatan sul­
fate is separated into two distinct bands. Heparan sulfate 
content is significantly decreased at day I and is further 
reduced 2 days after treatment. Chondroitin sulfate has re­
turned to control values at day 2. The nature of the GAGs, 
which was determined by agarose gel electrophoresis, was 
confirmed by enzymatic digestion (data not shown).
Analysis on cryosections of parenchymal lung tissue 
showed that dermatan sulfate and chondroitin sulfate are in­
creased at 3 h and 1 day, and at 1 day after treatment, respec­
tively, while the heparan sulfate content is significantly de-
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Figure 4. Chondroitin sulfate immunostaining of rat lung after instillation of 100 ¡imo\ jS-D-xyloside in 10% DMSO. (a) 3 h after instillation 
o f 10% DMSO (control); (b ) 3 h, and (c) 7 days after instillation of /3-D-xyloside; (d) phase contrast micrograph o f the same section as 
(r). N ote the increase in chondroitin sulfate staining after /3-D-xyloside treatment. At day 7, staining is focal and associated with elastin 
fibers (arrows in [cl and [¿/I). Bar: 20 um.
Figure 5. Heparan sulfate immunostaining of rat lung 3 days after instillation of: (a) 10% DMSO; (b ) 100 /¿mol /3-D-xyloside in 10% 
DM SO. Heparan sulfate is linearly distributed in alveoli in accordance with its presence in basement membranes. In /3-D-xyloside-treated 
rats the distance between the two (heparan sulfate-stained) basement membranes is increased, indicating edema (see arrow). Bar: 100 /¿ni.
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T A B L E  1
Urinary GAG content after instillation o f various agents
- • - ' m i  ■ - -  -  - . I . .  4 ''T ~
Day
Control 
(10% DMSO)
/3-D-xyloside 
(100 /¿mol)
/3-D-xyloside 
(20 jumol)
a-D-xyloside 
(25 /¿mol)
. V.. . * - -.
/j-nitrophenol
(50 /unol)
0 36.4 ± 2.0 (5) 37.1 w |« t 6.1 (10)
I •>. V • * . . w ** 4 J rt ■ . . kn, . ¿MW V t ^ (a W U
40.7 ±  4.5 (ID 36.5 ± 8 . 0 (9) 32.8 ±  6.1 (7)
1 38.9 ± 7.3 (5) 575.5 M >i|v 175.2* (10) 490.7 ±  125.9 * (ID 41.2 ±  8.9 (7) 40.6 + 14.8 (6)
2 42.9 i 2.4 (5) 45.9 ± 6.9 (8) 32.4 ±  9.3 (11) 45.7 ±  10.4 (4) 36.5 ±  15.6 (4)
3 38.3 ± 6.1 (5) 38.9 ± 7.4 (9) 33.5 ±  5.9 (ID 39.8 ±  17.7 (4) 28.6 ±  6.0 (4)
4 53.9 ± 8.1 (5) 57.5 ± 20.7 (9) 25.9 ±  6.4 (11) 34.1 ± 7 . 2 (4) 36.1 ± 12.3 (4)
5 36.2 I«*!*«« 5.0 (5) 43.5 ± 8.1 (9) n.d. n.d. n .  d .
6 39.6 ± 4.0 (5) 41.5 ± 6.0 (9) n .  d . n.d. n ,  d .
7 40.9 ± 6.4 (5) 42.9 ± 5.9 (9) n.d. n .  d . n.d.
Values are expressed a:
•..h.-.Tw--.«■. -  -.111...-.'. --
i  /¿g GAG/mg creatinine . The nu inber of rats; is indicated within parentheses. n.d.: not determined.
* P < 0.001 compared to all other Vidues.
creased 2 days after treatment (Table 4). All values return to 
control levels 7 days after treatment.
Elastase Activity in BAL Fluid
In /3-D-xyloside-treated rats, BAL fluid shows a modest in­
crease in elastase activity one day after treatment (3.2 ±  0.6
[n 3] versus 2.1 ±  0.4 ng /ml BAL fluid for control [10%
DMSO, n = 6 ] ) .  Levels are normal the second day.
Discussion
In this study we show that intratracheal instillation of 100 
/xmol /3-D-xyloside in rats induces the development of em­
physematous lesions. After treatment with 20 /xmo 1 /3-D-xylo­
side only about 30% of the animals developed emphysema­
tous lesions, indicating a dose-dependent effect of the drug. 
a-D-xyloside and the aglycon p-nitrophenol do not induce 
emphysematous lesions, indicating that the effect is specific 
for /3-D-xyloside. /3-D-xyloside mimics the serine-xyloside
GAG initiation site of the core protein of proteoglycans, and 
competes as a false acceptor for GAG synthesis (26). Ad­
ministration of /3-D-xyloside, but not «-D-xyloside or/>-nitro- 
phenol, increases GAG synthesis, which is particularly evi­
dent from the 15-fold increase of GAG content in the urine 
of treated rats. The increase comes mainly to the account of 
chondroitin and dermatan sulfates, which is typical for the 
/3-D-xyloside preparation we used (/?-nitrophenyl-/3-D-xylo- 
pyranoside) (37). The strong increase of urinary GAG con­
tent cannot be attributed solely to an increase in the synthesis 
of GAGs in the lung. Other organs, which possibly receive 
a dose of /3-D-xyloside indirectly through the blood, may 
also contribute. This especially applies to the kidney, since 
the GAG content in serum showed only a 2-lbld increase 
compared to the 15-fold increase in urine. In an organ perfu­
sion system, 2.5 mM /3-D-xyloside stimulated the synthesis 
of chondroitin sulfate and dermatan sulfate in glomeruli 
(38). The amount of increase in urinary GAG content 1 day 
after treatment is positively correlated to the extent of paren-
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Figure 6. Agarose gel electrophoresis o f  GAGs isolated from urine 
after instillation of 100 /¿mol /3-D-xyloside. The nature o f the differ­
ent GAGs was established using specific enzym es (32). The amount 
of GAGs applied corresponds to 1 ¡ig creatinine, except for lane D 
which corresponds to 0.08 pig creatinine. (A) day 0  (before instilla­
tion); (B) and (D) 1 day after instillation; (C) 2 days after instilla­
tion. M: reference GAGs (HS: heparan sulfate [6 ngj; DS: derma- 
tan sulfate [6 ng]; CS: chondroitin 4-sulfate [6 ng]).
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Figure 7. The relation between the mean linear intercept 40 days 
alter instillation of various agents, and the content of urinary GAGs 
l day after instillation. Rats were instilled with 0.5 ml containing 
: 100 /unol /3-D-xyloside; LI: 20 /¿mol j£#-D-xyloside; • :  25 /¿mol 
tv-D-xyloside; 0 : 50 /¿mol />-nilrophcnoI. Controls received ♦: 
10% DMSO; O: no treatment. There is a significant correlation be­
tween the increase of urinary GAG content and the M U . (r =
P < 0.002.)
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TABLE 2
Effect o f  intratracheal instillation o f 100 p 
ß-D-xyloside on chondroitin sulfate (CS) < 
dermatan sulfate (DS) content in serum of
t i w ' » — • t j k r . v v * ' "  - I I  ---------- . .. . ». .. p . . —  . .  *  É 1---—  */— — - I I J ,
Time after Instillation CS DS
... • —  - •• • • • s -  'S. -
corneal stroma, which leads to a reduced synthesis of derma- 
tan sulfate proteoglycans but an increase in free dermatan 
sulfate, resulted in a reduced collagen fibril packing and a 
disruption of lamellar organization (41). The situation may 
be somewhat analogous to cervical dilatation at the end of 
pregnancy, a process which is accompanied by a dramatic in­
crease in collagen-associated dermatan sulfate (42, 43). An 
increase of chondroitin sulfate content can impair elastic 
fiber assembly by inhibition of the binding of the 67 kD 
elastin-binding protein to elastic fibers and the cell mem­
brane (44). GAGs may further disturb repair of the alveolar 
matrix since they are potent inhibitors of lysyl oxidase (45), 
an enzyme crucial for the cross-linking of collagen and clas* 
tin. Ex vivo treatment of mouse embryos with /3-D-xyloside 
inhibited branching morphogenesis in the lung (46). Avail­
ability of growth factors may also be affected by the increase 
in GAGs; /3-D-xyloside-primed GAGs are able to bind 
chymal destruction observed at day 40. This indicates that growth factors, as do GAGs in proteoglycans (47), All these 
the degree of disturbance in the lung during the initial phase effects will compromise the delicate balance of alveolar wall 
of the insult determines the degree of parenchymal destruc- homeostasis and prevent an orderly repair, finally resulting
a  I  l  «  *  m  • *  *
Control (1 h) 
1 h 
3 h 
1 day 
3 days 
7 days
3.54 ±  0.36
5.55 ±  0.98* 
6.87 ±  0.32* 
8.33 ±  1.04* 
4.38 ±  0.34 
3.17 ±  0.12
2.21 ±  0.19  
5.48 ±  0.56*  
5.09 ±  0.43*  
5.12 ±  0.51*  
3.84 ±  0.41 
2.88 ±  0.44
Values are expressed as ^g/ml serum and are mean ± SD of four animals, 
* P < 0.05 versus control.
tion in a later phase.
Although the mechanism of the parenchyma] destruction 
due to /3-D-xyloside treatment is not clear, it is likely medi-
in parenchymal destruction and emphysematous lesions 
In 0-D-xyloside-treated rats only mild hemorrhages and 
inflammation were observed in the lung, in contrast to pancre
ated by the increase in synthesis of free GAGs and the con- atic elastase-treated animals (Figure 1) (25). This could be
comitant decrease in proteoglycan synthesis. In BAL fluid an effect of DMSO which was used as a solvent for/3-D-xyio-
and parenchymal lung tissue we found an increase in total side. DMSO acts as an anti-inflammatory agent and is a
GAG content due to an increase in dermatan and chondroitin scavenger of free radicals (48). The increase in free elastase
sulfates, but heparan sulfate was decreased. We did not ob- activity measured in the BAL fluid is only moderate. Apart
serve a clear decrease in heparan sulfate proteoglycans of from the mild infiltration of inflammatory cells, this may
the alveolar basement membrane using immunofluores- also be an effect of the increase in GAGs which arc
cence. Others, however, found a 25% decrease in basement inhibitors of neutrophil elastase (14, 15). Hemorrhages and
membrane proteoglycans (predominantly heparan sulfate inflammation may not play an important role in alveolar tis-
proteoglycans) with ruthenium red staining in mouse sub sue degradation in ß-D-xyloside-treated rats. The total free
mandibular salivary glands (39). A 43% decrease in hep- elastase activity in BAL fluid is 64 ng/rat, which stands
aran sulfate synthesis, together with a 4-fold increase in chon small compared to the amount of neutrophil elastase neces
droitin sulfate synthesis was observed after 0-D-xyloside sary to induce pulmonary emphysema by intratracheal instil- 
treatment of the basement membrane producing EHS (Engel- lation (about 300 jug neutrophil elastase 149)). However,
breth-Holm-Swarm) tumor in vitro (40). Basement mem some damage to the alveolar wall due to inflammation and
brane heparan sulfate proteoglycan is believed to function as neutrophil elastase cannot be excluded.
a charge barrier for proteins. A probable loss of heparan sul­
fate proteoglycans together with an increase in total GAGs,
The importance of proteoglycans in the stability of the 
lung parenchyma has recently been demonstrated. Intra-
which possess high water-binding properties, may account trachéal instillation of testicular hyaluronidase (which de-
for the observed edema in the treated rat lungs. grades hyaluronate and dermatan sulfate and chondroitin
The observed increase in dermatan and chondroitin sul- sulfate) followed by exposure to a nontoxic concentration of
fates content may destabilize collagen fibrils and reduce their oxygen (60% ) results in a significant air-space enlargement
tensile strength. /5-D-xyloside treatment of developing avian in hamster lungs (50). Hyaluronidase instillation also aug-
TABLK3
Effect of intratracheal instillation of 100 /xmoI ß-D-xyloside on heparan sulfate (HS) , 
dermatan sulfate (DS), and chondroitin sulfate (CS) content in BAL fluid o f rats
M V . * . —  ---------- -----------------------------------------------------------------------------------------------------------------,  .  ...................  ........................................................................................................................... .................................... ................................................................... , . A . ,  . . . . . . . .  . . .  .............................................................
CS
3 h
1 day
2 days
. . »  --------- , --------. . .  .......... , _ , . .,.
Values arc expressed as /tg/ml BAL fluid and are mean ± SD of lour animals.
* P < 0.01 versus control.
Time after Instillation HS
------------------------------------------------- ------------------------------- ---- ---------- ----------------------- --------- ------------------ ------ ----------------- -----------------------------------------------. . . . ----------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------. . . . . . . .  . . . .  . .  . . . .  , ................................................ ...
Control (1 h) 0.24 ±  0.06 0.07 ±  0.03 0.02 i 0.02
1 h 0.19 ± 0.02 0.68 ± 0.05* 0.71 I: 0.12*
0.14 ± 0 .0 6  1.14 ± 0.21* 0,80 f 0.20*
0.09 ± 0.02* 0.29 ± 0.06* 0.94 t (1.13*
0.02 ± 0.01* 0.08 f  0.04 0.12 + 0.04*
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T A B L E  4
Effect o f intratracheal instillation o f 100 ¿umol 0-D-xyloside on heparan sulfate (HS), dermal an sulfate (DS), and
chondroitin sulfate (CS) content in parenchymal lung tissue o f rats
Time after Instillation HS CS
■ —  ■■■* —  L v r * »  i •'
Control (1 h) 
1 h 
3 h
I clay 
clays
7 days
• •  »  ■ -  m  . ■ --  t w  r- i -■ U . » H I V -  >■ ■■ I I . w w  r — — »  ■1
2.05 ±  0.66 (11) 
2.91 (1)
1.63 ±  0.43 (4) 
1.72 ±  0.22 (4) 
1.13 ± 0 .1 0  (3)* 
2.00 ±  0.63 (3)
'."T'S I *' *
0.67 ±  0.24 (13) 
0.74 (I) 
0.84 ±  0.21 (4) 
2.06 ± 0 .6 0  (4)1' 
0.50 ±  0.08 (3) 
0.58 ±  0.10 (3)
k  . —  *— t_». »- i ■' J  *. %  il. ■ | «  . —  . « » >  \*/ m t ^  -
jws *'i v*ir'^.»»fcfc.-Tr—
» .  J  - —  .!■ -
Values are expressed as /¿g G A G /m g protein and are mean ±  SD of the number of analyzed animals (shown in parentheses)
* P <  0.05.
1 P < 0.01 versus control.
. — . —  ■■ •.. i . -k ,i m  ■ r .  *  ^ ^ J i  t " v  ’ i * ^ i  1
DS
... *. « .*•.-, w—*-■ •
2.51 ±  0.56 (13) 
3.46 (1)
3.44 ±  0.41 (4)t 
4.50 ± 0.48 (4)1 
3.16 ±  0.98 (3)
2.44 ±  0 .35 (3)
ments pancreatic elastase-induced parenchymal destruction 
(5 1). We showed an increase of urinary GAGs and a decrease 
of lung GAGs and heparan sulfate proteoglycans shortly after 
pancreatic elastase instillation into rat lungs (25). The uri­
nary GAG content correlated also to the extent of emphy­
sema developed after 40 days.
In conclusion, a single intratracheal instillation of a high 
dose of /3-D-xyloside results in the development of em­
physematous lesions. This effect is likely mediated by the 
short-term increase of free GAG chains (and possibly the de­
crease of proteoglycan content). It underscores the impor­
tance of proteoglycans in alveolar wall integrity and indi­
cates their involvement in the pathogenesis of emphysema. 
/3-D-xyloside treatment may be an alternative experimental 
way to induce emphysema. The detrimental effect of /3-D-xylo­
side on the lung should be taken into consideration when 
evaluating /3-D-xyloside preparations as antithrombotic
drugs (52).
Acknowledgment: This work was supported by a grant from the Dutch Asthma 
I"huiulatinn (project no. 89.14).
References
1. Gadek, J. E ., and E. R. Pacht. 1990, The protease-antiprotease balance
within the human lung: implications for the pathogenesis of emphysema.
Li MX Supp /. 168: 5 5 2 - 564.
2. Weissler, J. C. 1987. Pulm onary emphysema: current concepts of* patho­
genesis. Am, J. Med. Sci. 203 :125-138 .
Snider. G. L. 1992. Emphysema. The first two centuries and beyond. A 
historical overview, with suggestions for future research. 2. Am. Rev. 
Res pi r. Dis. 146:1615 1622.
4. Hoidal, J. R., IX E. N iew oehner, N. V. Rao, and M. S. Hibbs. 1985. The 
role of neutrophils in the development o f  cadmium chloride-induced em 
physema in lathyrogen-fed hamsters. Am. J. Pathol. 120:22-29.
5. Snider, G. L., E. C, Lucey, B. Faris, Y. Jung Legg, P. J. Stone, and C. 
Franzblau. 1988. Cadm ium -chloride-induced a irsp ace  enlargement with 
interstitial pulmonary fibrosis is not associated with destruction of lung 
elastin. Implications for the pathogenesis o f  human emphysema. Am. Rev. 
Respir. Dis. 137:918-923.
6. Riley, D. J . ,  M. J. Kramer, J. S. Kerr, C. U. Chae, S. Y. Yu, and R. A. 
Berg. 1987. Damage and repair o f  lung connective tissue in rats exposed 
to toxic levels o f oxygen. Am. Rev. Respir. Dis. 135:441-447.
7. D’Armiento, J .,  S. S. Dalai, Y, Okada, R. A. Berg, and K. Chada. 1992. 
Collagenase expression in the lungs o f  transgenic mice causes pulmonary 
emphysema. Cell 71 :955-961 .
8. van Kuppevelt, T . H ., F. P. M. Crem ers, J. G. W. Domen, H. M. van 
Beuningen, A. J. C. Van den Brule, and C. M. A. Kuyper, 1985. Ultra“ 
structural localization and characterization of proteoglycans in human 
lung alveoli. Eur. J. Cell BioL 36 :74-80 .
9. Sannes, P. L .,  K. K. Burch, and J. Khosla. 1992. Immunohistoehemieal 
localization of epidermal growth factor and acidic and basic fibroblast 
growth factors in postnatal developing and adult rat lungs. Am. J. Respir.
Cell Mot. Biol. 7 :230-237.
10. Heremans, A., B. De Cock, J, J, Cass ¡man, H. van den Berg he, and G.
David. 1990. The core protein of the matrix-associated heparan sulfate 
proteoglycan binds to fibroneetin. / ,  BioL Chem. 265:8716-8724.
11. Yamaguchi, Y., D. M, Mann, and E. Ruoslahti. 1990. Negative regulation
of transforming growth faetor-0 by the proteoglycan deeorin. Nature 
346:281-284.
12. Lortatjacob, H ., and J, A. Gritnaud. 1991. Interferon-gamma binds to hepa­
ran sulfate by a cluster o f  amino acids located in the C-terminal part of
the molecule. FEES Lett. 280:152-154.
LI Webb, L. M. C ,  M. U. Ehrengruber, I. Clarklewis, M, Baggiolini, and A. 
Rot. 1993, Binding to heparan sulfate o r  heparin enhances neutrophil re­
sponses to interleukin-8. Proc. NatL Acad, Sci. USA 90:7158-7162.
14. Walsh, R. L ., T. I  Dillon, R. Scicchitano, and G, McLennan. 1991. Hepa­
rin and heparan sulphate are inhibitors of human leucocyte elastase. Clin.
Sci. 81:341-346.
15. Rao, N. V., T. P. Kennedy, G. Rao, N. Ky, and J. R. Hoidal. 1990. Sulfated
polysaccharides prevent human leukocyte elastase-induced acute lung in­
jury and emphysema in hamsters. Am. Rev. Respir; Dis. 142:407-412.
16. Lafuma, C ,  E. Frisdal, A. Harf, L. Robert, and W. Hurnebeek. 199L
Prevention of leucocyte elastase-induced emphysema in mice by heparin 
fragments. Eur. Respir; J. 4:1004-1009»
17. Danielsen, C. C. 1982. Mechanical properties of reconstituted collagen
fibrils. Connect. Tissue Res. 9:219-225.
18. Vogel, K, G., M. Paulsson, and D. Heinegard. 1984. Specific inhibition of
type I and 11 collagen fibriltogcnesis by the small proteoglycans of tendon. 
Biochem. J. 223:587-597.
19. Garg, A. K., R. A. Berg, F. H. Silver, and H, G. Garg. 1989. Effect of pro­
teoglycans on type I collagen fibre formation. Biomaterials 10:413-419,
20. Werb, Z . , J. Banda, and P. A. Jones. 1980. Degradation of connective tissue
matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and col­
lagen by proteinases isolated from macrophages. J, Exp. Med. 152:1340- 
1357.
21. Stone, P. J. 1990. Perspective. Degradation of extracellular matrix pro­
teoglycans by human neutrophils. Am. J . Respir. Celt Mot. Biol. 2: 
491 492.
Stone, P. J . ,  M. P. McMahon, S. M. Morris, J. D. Calore, and C\ Franz- 
blau. 1987. Elastin in a neonatal rat smooth muscle cell culture has greatly 
decreased susceptibility to proteolysis by human neutrophil elastase, An 
in vitro model of elastolytie injury, In Vitro Cell Dev. Biol. 23:663 676.
23. Cileisner, J. M .t and C\ J. Martin, 1986. Lung tissue tension and glyeo-
saminoglyeans, Respir. Physiol. 66:247 258,
24. Thurlbeck, W. M. 1993. Emphysema then and now, Can. Respir. J. 1:
21 39.
25. van de Lest, C. H. A,, E. M. M. Versteeg, J. H. Veerkamp, and T. H.
van Kuppevelt. 1995. Digestion of proteoglycans in porcine pancreatic 
elastase-induced emphysema in rats. Eur. Respir. J. 8:238 245,
26. Sobue, M ., H. Habuchi, K. Ito, H. Yonckura, K. Oguri, K. Sakurai, and
S. Kamohara. 1987. /J-D-xylosides and their analogues as artificial initia­
tors of glycosaminoglyean chain synthesis. Aglyeonc-relatcd variation in 
their effectiveness m vitro and in vivo. Biochem. J. 241:591-601.
27. Potter-Perigo, S., K. R. Braun, E. Schonherr, and T. N. Wight. 1992. A\~
tered proteoglycan synthesis via the false acceptor pathway can be dis­
sociated from /S-D-xyloside inhibition of proliferation, Arch. Biochem. 
Biophys. 297:101409.
28. van den Born, J., L. P. W. J, van den Heuvel, M. A, H. Bakker, J. H. Veer­
kamp, K. J. M. Assmann, and J. H. M. Berden. 1992. A monoclonal anti­
body against GBM heparan sulfate induces an acute selective proteinuria 
in rats. Kidney Int. 41:115-123.
29. Hoffman, P. 1968. The chemistry of the protein-polysaceharides of connec­
i
84 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL. 16 1997
tive tissue. In The Chemical Physiology of Mucopolysaccharides. G. 
Quintarelli, editor. J. & A. Churchill Ltd., London. 39-49,
30. Mauderly, J. L. 1977. Bronchopulmonary lavage of small laboratory
animals. Lab. Anim. Sci. 27:255-261.
31. Goldner, J. 1938. A modification of the Masson trichrome technique for rou­
tine laboratory purposes. Am. J. Pathol. 14:237.
32. Lowry, O. H., N. J. Rosenbrough, A, L. Farr, and R, J. Randall. 1951. Pro­
tein measurement with the Folin phenol reagent. J, Biol. Chem. 193: 
265-275.
33. van de Lest, C. H. A., E. M. M. Versteeg, J. H. Veerkanip, and T. H. van
Kuppevelt. 1994. Quantification and characterisation of glycosaminogly- 
cans at the nanogram level by a combined azure A-silver staining in 
agarose gels. Anal. Biochem. 221:356-361.
34. Farndale, R, W,, D. J. Buttle, and A. J. Barrett. 1986. Improved quantitation
and discrimination of sulfated glycosaminoglycans by use of dimethyl- 
methylene blue. Biovhim. Biophys. Acta 883:173-177.
35. Castillo, M. J., K. Nakajima, M. Zimmerman, and J. C. Powers, 1979. Sen­
sitive substrates for human leukocyte and porcine pancreatic elastase: a 
study of the merits of various ehromophorie and fluorogenic leaving 
groups in assays for serine proteases. Anal. Biochem. 99:53-64.
36. Kirkwood, B. R. 1989. Essentials of Medical Statistics. Blackwell Scientific
Publications, Oxford.
37. Lugemwa, F. N., and j, D. Esko, 1991. Estradiol /J-D-xyloside* an efficient
primer for heparan sulfate biosynthesis. J. Biol. Chem. 266:6674-6677.
38. Kanwar, Y. S,, V, C. Hascall, M . L. Jakubowski, and J. T. Gibbons. 1984,
Effect of /J-D-xyioside on the glomerular proteoglycans. L Biochemical. 
J. Cell Biol. 99 :715-722.
39. Spooner, B. S., A. Paulsen, and M. S. Sullins. 1989. /3-Xytoside effects on
basal lamina structure and anionic site distribution in the embryonic 
mouse submandibular salivary gland. Arch. Oral Biol. 34:541-549.
40. Ledbetter, S. R., a n d !  R. Hassell. 1986. /3-D-xyloside-mediated alteration
in the synthesis of basement membrane proteoglycan. Arch, Biochem. Bio- 
phys. 246:403-410.
41. Hahn, R. A., and D. E. Birk. 1992. /3-D xyloside alters dermatan sulfate
proteoglycan synthesis and the organization of the developing avian cor­
neal stroma. Development 115:383-393.
42. Kokenyesi, R., and J, F. Woessner. 1991. Effects of hormonal perturbations
on the small dermatan sulfate proteoglycan and mechanical properties of 
the uterine cervix of late pregnant rats. Connect. Tissue Res. 26:199-205.
43. Rechberger, T,, and J. F, Woessner. 1993. Collagenase, its inhibitors, and
decorin in the lower uterine segment in pregnant women. Am. J. Obstei 
Gvnecoi 168:1598-1603.
44. Hinek, A ., J. Boyle, and M. Rabinovitch. 1992. Vascular smooth muscle
cell detachm ent from elastin and migration through elastic laminae is 
promoted by chondroitin sulfate-induced “shedding” of the 67-kDa cell 
surface elastin binding protein. Exp. Cell Res. 203:344-353.
45. Gavriel, P., and H. M. Kagan. 1988. Inhibition by heparin of the oxidation
of lysine in collagen by lysyl oxidase. Biochemistry 27:2811-2815.
46. Smith, C. L , S. R. Hilfer, R. L. Searls, M. A. Nathanson, and M. D, Al-
lodoli. 1990. Effects of /3-D-xyloside on differentiation of the respiratory 
epithelium. Dev. Biol 138:42-52.
47. Miao, H. Q., T> A, Fritz, J. D. Esko, J. Zimmerman, A, Yayon, and 1.
Vlodavsky. 1995. Heparan sulfate primed in 0-D-xylosides restores bind­
ing of basic fibroblast growth factor, J. Cell. Biochem. 57:173-184,
48. Haschek, W. ML, K. E. Baer, and J. E. Rutherford. 1989. Effects of dimethyl
sulfoxide (DM SO) on pulmonary fibrosis in rats and mice. 7oxicohqv 
54:197-205.
49. Breuer, R ., T. G, Christensen, E. C. Lucey, G. Bolbochan, P. J. Stone, and
G. L, Snider. 1993. Elastase causes secretory discharge in bronchi of ham­
sters with elastase-induced secretory cell metaplasia. Exp. Lung Res 
19:273-282.
50. Cantor, J. O,, J, M. Cerreta, G. Armand, S, Keller, and G. M. Turino. 1993.
Pulmonary air-space enlargement induced by intratracheal instillment of 
hyaluronidase and concomitant exposure to 60-percent oxygen. Exp. Luiit* 
Res. 19:177-192.
51. Cantor, J. O., J. M. Cerreta, S. Keller, and G. M, Turino. 1995. Modulation
of air space enlargement in elastase-induced emphysema by intratracheal 
instillment o f  hyaluronidase and hyaluronic acid. Exp. Lung Res. 21:
423-436.
52. Masson, P. J., D. Coup, J. Millet, and N. L. Brown. 1995, The effect of
the /3-D-xyloside naroparcil on circulating plasma glycosaminoglycans. 
An explanation for its known antithrombotic activity in the rabbit. J. Biol. 
Chem. 270:2662-2668.
